Eli Lilly seeks to quell drug price anger with cheaper insulin

Major drugmakers including Lilly, a leading producer of insulin, have come under fire from patients and lawmakers over the rising cost of the life-saving medication used to treat diabetes.Lilly's rebranded product will be called Insulin Lispro, while Humalog, which makes $3 billion in annual sales, will remain available for those wishing to access it through existing insurance plans.The cost of insulin for treating type 1 diabetes in the United States has nearly doubled over a five-year period,